This is the authors' abstract. We don't add key points for this paper.
Introduction Inherited retinal diseases (IRDs) are a major cause of blindness in the working-age population. The emergence of gene and cell therapies has highlighted the need for sensitive outcome measures, capable of detecting subtle retinal changes.Areas covered Adaptive optics imaging enables in vivo visualization of individual photoreceptor cells and microvasculature, offering a unique opportunity to assess treatment effects at the cellular level. This review outlines the principles and adaptations of adaptive optics imaging along with structural and functional-derived outcome measures that have been used to date in IRDs. Evidence from interventional IRD trials is summarized, demonstrating how adaptive optics imaging has been applied to monitor photoreceptor and microvascular integrity following treatment.Expert opinion Current challenges are discussed including technical limitations, automation, standardization of imaging and analysis protocols, commercial implementations, and the lack of regulatory acceptance. Adaptive optics imaging has evolved from an exploratory research tool into a promising candidate for future clinical trial endpoints. With ongoing advances, adaptive optics derived biomarkers could soon play a pivotal role in assessing therapeutic efficacy in inherited retinal disease treatment trials.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Grewal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: